Alternative, Scalable Synthetic Routes for Phase II-ready Small Molecule
Pays $50,000 for a scalable, low-cost synthesis route for a Phase II drug candidate.
Alternative, Scalable Synthetic Routes for Phase II-ready Small Molecule is a challenge from an undisclosed pharmaceutical company, posted as an InnoCentive 'Seeker,' paying $50,000 to chemists, process-chemistry experts, start-ups, academic groups and organisations who can propose an alternative synthetic route to manufacture a specific clinical-candidate small molecule — a delta opioid receptor …
Looking for chemists, process-chemistry experts, start-ups, academic groups and organisations proposing an alternative synthetic route to manufacture a specific clinical-candidate small molecule (a delta opioid receptor agonist for neuropathic pain) at multi-tonne, GMP-ready scale. Solutions should sit at Technology Readiness Level 4-6 and keep cost of goods below 3,000 EUR/kg API, ideally under 1,000 EUR/kg.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
Similar grants
Browse the directory →
MIT Solve Global Challenges
🇺🇸MIT · United States
Supports teams tackling global challenges by selecting and backing scalable ideas through MIT Solve challenge pathways.
NOURISH: Autoimmunity Digital Health Challenge
🇺🇸OADR-ORWH · United States
Awards up to $650,000 across three phases for digital tools tracking autoimmune nutrition.
Lupus Insight Prize
LRA · United States
Provides prize recognizing a specific significant recent lupus research discovery through the Lupus Insight Prize.
Oligonucleotide Toxicity (OligoTox) Open Data Challenge
🇺🇸NCATS · United States
Pays cash prizes for public datasets that help predict oligonucleotide drug toxicity in human cells.
TRDNT Challenge Phase II: Prototype Development and Use Case Demonstration
🇺🇸NIH · United States
Pays up to $120,000 per Interim Milestone winner and up to $320,000 per Final Submission winner to US-based researchers, startups and institutions that build a working prototype technology able to target endogenous RNA in human disease.
Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge
🇺🇸NIH · United States
Awards up to $13.1 million across three phases to US-based teams developing novel technologies that target RNA to treat human disease.